C
LABU icon

Covestor’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Covestor’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$76K Sell
261
-458
-64% -$87.6K 0.04% 528
2026
Q1 		$119K Buy
719
+271
+60% +$44.5K 0.08% 220
2025
Q4 		$71K Buy
+448
New +$61.5K 0.04% 759

Other funds holding LABU

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
GS
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
EFG
Ethos Financial Group King Of Prussia, Pennsylvania $1.5B AUM 22.75% 1-Year Est. Return

Covestor's LABU Position: Q2 2026 in Review

Covestor reduced its Direxion Daily S&P Biotech Bull 3X ETF (LABU) stake by 64% in Q2 2026, selling an estimated $87.6K and leaving 261 shares worth $76K. The position accounts for 0.04% of the portfolio, ranked #528.

Covestor first reported a position in LABU in Q4 2025 and has held it in 3 quarters since. The position peaked at $119K in Q1 2026. 36 funds tracked by Wall St. Rank hold LABU as of Q2 2026.

  • Covestor held 261 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $76K as of Q2 2026.
  • Covestor sold 458 Direxion Daily S&P Biotech Bull 3X ETF shares in Q2 2026, an estimated $87.6K.
  • Direxion Daily S&P Biotech Bull 3X ETF made up 0.04% of Covestor's portfolio in Q2 2026, its #528 holding.
  • Covestor first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2025 and has held it in 3 quarters since.
  • Covestor's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $119K in Q1 2026.
  • 36 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.